Jan 18-24, 2014: Visit AMO at the Hawaiian Eye Meeting in Kauai, HI More Info
Globally, we are number one in LASIK; number two in cataract, where we are growing our position with the TECNIS® platform; and we are number three in eye care solutions. Our Vision Care pipeline is balanced across each segment, with a number of products launching over the next five years.
Click here to learn more about AMO's products.
The global demand for vision care is on the rise, as the baby boomer population ages and vision care becomes more affordable in less-developed countries. Geographically, 65 percent of Abbott’s Vision Care sales are generated outside the United States, with further expansion underway in emerging markets such as China and India.
Abbott’s vision care business employs nearly 4,000 people worldwide and has a presence in more than 60 countries.
Abbott plans to introduce a number of new vision products during the next few years. In addition to new product launches, Abbott is expanding its vision care presence in markets around the world.
Click here to read about AMO's history.
Abbott is dedicated to further improving vision care for patients around the world. Our research and development group represents a full breadth of ophthalmic surgical technology skill and expertise, extensive knowledge of biomaterials and proficiency in eye care formulation chemistry. Abbott’s vision care team of knowledgeable, experienced employees around the world – including scientists, engineers, and marketing, sales and technical experts – works together to advance the science of vision. In addition, we collaborate with premier academic institutions to supplement our internal study.
Click here to view our Environmental, Health and Safety Policy.